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Improving Folic Acid Consumption in Women at Risk for
Neural Tube Defects in Florida
Jessica C. Bishop-Royse, MS, Elizabeth Jensen, BA, Melanie Simmons, PhD
ABSTRACT
Two providers who participated in the Florida VitaGrant program, a site providing early childhood services to
primarily Mexican Hispanic families (Site A) and a site providing home visiting services to pregnant women and
families with infants (Site B), are presented as alternative models for improving folic acid levels in reproductive
aged women in Florida. Site A distributed multivitamins and education in the context of health education provided
to women in a group setting, once a month. Site B provided the services primarily through home visits of varying
frequency. Folic acid knowledge and consumption were measured at program initiation and at a follow-up date to
determine levels of improvements for both sites, by demographic characteristics. Analyses comparing age, race, and
ethnicity of women served by Site A were compared to women served by Site B. These programs were then
evaluated in-depth with respect to baseline and follow-up levels of folic acid knowledge and consumption of their
participants. Site A seemed to be somewhat more effective at improving the knowledge and consumption patterns
of its participants than Site B, although both experienced significant improvement overall. Initially, women who
received services from Site A reported lower levels of baseline knowledge and multivitamin consumption than Site
B clients. However, Site A clients reported higher levels of knowledge and consumption at follow up than Site B
clients. The findings suggest that free multivitamin distribution and pre/interconception education can dramatically
increase MVC among all participants. Program delivery that takes place in the context of a group setting may be a
particularly effective way to reach women at-risk for neural tube defects.
Florida Public Health Review, 2009; 6, 36-45.
Introduction
Public health research has suggested that the
diets of pre-conceptional women in the U.S. have
deteriorated in the past 30 years (Putnam & Gerior,
1999). This may have important implications for
some health diseases and conditions such as neural
tube defects (which are thought to occur when
maternal levels of folate are not adequate to support
early neurological activity). The Centers for Disease
Control and Prevention (CDC) have recommended
that regardless of their intention to get pregnant,
women of childbearing ages should consume an
adequate amount of folate, in order to prevent neural
tube defects (“Recommendations for folic acid,”
1992). Despite the fortification of many foods with
folic acid (the synthetic form of folate, a form of Bvitamin), current levels of dietary folate are
inadequate for preventing neural tube defects
(Watkin, 1998; Werler, Hayes, Louik, Shapiro, &
Mitchell, 1999). Because folate is usually added to
multivitamins, the CDC has recommended that all
women aged 14-45 consume multivitamins
containing 0.4 mg (400µg) of folic acid on a daily
basis (“Recommendations for folic acid,” 1992).
Some research has estimated that daily consumption
of multivitamins (MVC) that contain folic acid can
prevent up to 70% of NTDs (Posner et al., 2006;
Florida Public Health Review, 2009; 6:36-45.
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Buttriss, 2004; Czeizel & Dudás, 1992; MRC
Vitamin Study Research Group, 1991).
Even though folic acid supplements have been
found to reduce the risk of neural tube defects (if
taken prior to and in the first few weeks of
pregnancy), a substantial proportion of women of
childbearing age do not consume folic acid enriched
supplements (MMWR 2008; Goldberg et al., 2006).
Since a large proportion of pregnancies in Florida and
the United States are unplanned (Williams et al.,
2006), women who are not taking folic acid are
placing their unplanned pregnancies at an increased
risk for a NTD (Atrash, Johnson, Adams, Cordero, &
Howse, 2006). Additionally, other maternal
characteristics also seem to be associated with higher
occurrence of NTDs, such as young maternal age
(aged 14-19), Hispanic ethnicity (Czeizel & Dudas,
1992), Mexican origin (Suarez et al., 2000, Blatter et
al., 1994), low socioeconomic status (Blatter, Van der
Star, & Roeleveld, 1994; Eichholzer, Tonz, &
Zimmerman, 2006; and Wasserman, Shaw, Selvin,
Gould, & Syme, 1998) and foreign born nativity
status (Correia & Hauser 2007). In Florida, women
who are poor, Hispanic, non-Hispanic Black and
younger than 25 years old are less likely to be
consuming folic acid compared to other groups and
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are at increased risk for having a NTD affected
pregnancy (Florida BRFSS, 2007).
During the period 1998-2004 in Florida, about
one infant in every 2000 live births was born with a
neural tube defect (NTD) such as spina bifida and
anencephaly (Correa & Hauser, 2007). To reduce the
occurrence of neural tube defect affected births, the
Florida Department of Health and the March of
Dimes Florida Chapter cooperated on a joint project,
implementing the Florida VitaGrant Program. This
program provided free preconception educational
materials and multivitamins to women of
childbearing age.
The purpose of the VitaGrant
Program was to prevent neural tube defect affected
births by addressing some of the socio-demographic
factors known to be associated with NTDs, through
education and multivitamin supplementation, which
has been shown to be effective (Smithells, Sheppard,
& Schorah, 1976; Slattery & Janerich, 1991; Botto,
Moore, Khoury, & Erickson, 1999; Platzman, 1998).
The VitaGrant Program focused on increasing
preconception health knowledge as well as folic acid
awareness and consumption among at-risk and
medically underserved women of childbearing age.
This was accomplished through preconception
education, multivitamin distribution provider training
and a statewide media campaign.
A unique
component of the VitaGrant Program was that
culturally appropriate educational materials were
distributed to Hispanic women in order to better
inform Spanish-speaking program participants of the
benefits and importance of taking folic acid.
Throughout
Florida,
over
265
non-profit
organizations and agencies joined in the effort to
distribute folic acid enriched multivitamins as well as
preconception education materials. The partnership of
these organizations resulted in the distribution of over
half a million bottles of vitamins to program
participants.
Presented here are the findings from a process
evaluation that assessed the improvement in folic
acid consumption and knowledge that occurred for
participants at two different sites, a site providing
early childhood services to primarily Mexican
Hispanic families (Site A) and a site providing home
visiting services to pregnant women and families
with infants (Site B). This evaluation was conducted
using data collected throughout participation in the
Florida VitaGrant Program that distributed free
multivitamins containing folic acid and provided
education and training for women aged 14-45 in
Florida during the period 2005-2007.
Methods
There are several types of data that were
generated during the course of the VitaGrant
Florida Public Health Review, 2009; 6:36-45.
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Program.
First, program providers collected
information on the distribution of bottles of vitamins.
The age, race and ethnicity of women who received
vitamins was recorded and compiled into a
centralized dataset that provided aggregate statistics
to program administrators to determine how well “atrisk” populations were reached by the program.
VitaGrant program providers were surveyed about
their experiences in conducting this public health
improvement effort (combining education with
vitamin distribution), which make up the second
source of data. VitaGrant clients were interviewed at
initiation and then again at follow-up, when they
returned for services. Their answers composed the
third source of data, which is the focus of this
particular investigation.
Each time VitaGrant clients were interviewed, it
was with a program provider in the context of a
health or social service setting. The instrument
contained a variety of measures, which asked about
pregnancy history, folic acid knowledge, and folic
acid consumption as well as barriers to daily
multivitamin consumption (MVC) and demographic
measures such as age, ethnicity and race. At baseline,
the knowledge item was in the form of a question
which was posed to program participants, asking,
“Based on what you have heard, seen or read, should
a woman take multivitamins before her pregnancy or
not?” To which the participants answered “Yes,”
“No,” “Don’t Know,” and “Maybe.” The
“consumption” item is a combination of three other
measures; one that asked “Do you currently take
multivitamin pills or supplements?” Another
interview question asked, “Are any of these a
multivitamin?” both of which were answered either
“Yes,” “No,” or “Don’t Know/Not Sure.” Finally, a
question that asked about the frequency of
consumption, “How often do you take this vitamin
pill or supplement?” The answer choices for this item
were “Times per day ____,” “Times per week____,”
“Times per month____,” and “Don’t know/Not
sure____.”
The survey was changed somewhat at follow-up
such that the knowledge item was a checklist of
statements that were selected if the participant
answered affirmatively. The knowledge item asked,
“What have you read, heard or seen about folic
acid?” The answer choices provided were: “Prevents
birth defects/Neural Tube Defects/Spina Bifida,”
“Need is greater in pregnancy,” “Should be taken
before pregnancy,” “Good for you/Good to
take/Important,” “Important for baby development,”
and “Don’t know.” The questions about consumption
are as follows: “Are you currently taking the
multivitamins provided?” and “How often?” A
question about barriers to daily MVC was added to
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the follow-up survey, which asked “What are the
challenges to taking it every day?” where the
participants selected “Can’t remember,” “Pill too
big,” “Makes me sick,” “Doesn’t seem important,”
and “Other.”
Site A
Background
Florida ranks 4th among U.S. states with the
largest Hispanic populations in the United States
(Guzman, 2001). Much of the risk for Hispanics in
Florida stems from the fact that the majority are
foreign-born Mexican, who have been shown to have
increased odds of having neural tube defect births
(Correia & Hauser, 2007). It has been suggested that
much of the increased risk of neural tube defect births
for Hispanics is due to low maternal folate levels,
perhaps driven by the diets of foreign-born women.
Since up to 70% of neural tube defect births are
preventable (Buttriss, 2004; Czeizel & Dudás, 1992,
MRC Vitamin Study Research Group, 1991) with
adequate levels of maternal folate, it would seem that
it is in the best interest of public health practitioners
to ensure that Hispanic women have access to an
adequate supply of folate.
Target Population
Site A serves primarily Mexican-Hispanic
families residing in and around southeast Florida.
Most of the women who received VitaGrant Program
services through Site A, had children who received
early childhood education services through Site A.
Program Description
Site A is a non-profit, non-sectarian organization
that provides child development services to farm
worker families. Mexican-origin women aged 25-29
comprised the majority of women who received
services at Site A. Most of the women who received
services at Site A interacted with the program daily
as their children received childcare services through
the site. Additionally, women who received services
at Site A attended monthly meetings with other
women and program staff where they received
education and free multivitamins. Despite the large
number of women who had already given birth, most
were unaware of the preventative effects of folic acid
when they were enrolled in the program.
Results of the Program Evaluation
Participation
Most of the 291 women receiving services at Site
A were between the ages of 25 and 29 years old
(36.77%). Women older than 30 made up about 32%
of the clients served, where women younger than 25
comprised about 27%. Over 91 percent of the women
served by Site A were Hispanic (the majority of
which reported Mexican-Hispanic ethnicity). NonFlorida Public Health Review, 2009; 6:36-45.
http://health.usf.edu/publichealth/fphr/index.htm
Published by UNF Digital Commons, 2009

Hispanic Whites and Blacks made up 3.44% and
2.75% of the remaining participants.
Table 1. Demographic Characteristics of Site A
Participants
Site A
Age
Less than 25 years old
25-29
Older than 30 years old
Missing
Total
Race and Ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic (99% Mexican)
Unknown/missing
Total

n
80
107
94
10
291
n
10
8
267
6
291

%
27.49%
36.77%
32.30%
3.44%
100.00%
%
3.44%
2.75%
91.75%
2.06%
100.00%

Outcomes
Knowledge. Table 2 shows that of the women
who participated in the VitaGrant program through
Site A, only 3.4% overall reported at baseline that
they were aware of the preventative effects of folic
acid for birth defects. At follow up, this increased to
over 91% who indicated that they were aware of the
preventative effects of folic acid for birth defects. In
terms of age, ≤ 5% or less of participants in each of
the age groups knew that folic acid prevents NTDs.
Knowledge increased substantially at follow-up, such
that almost 90% of women younger than 25 years,
89% of women ages 25 to 29 years, and about 96% of
women age 30 and over reported improved
knowledge. Among Hispanic women, 99% of whom
were of Mexican-origin, only 3% reported knowledge
at baseline. This figure increased to almost 92% at
follow-up.
Consumption of multivitamins (MVC).
At
baseline, only 6.2% of Site A clients consumed
multivitamins (Table 2). Following education and
program participation, this increased to 87.6%.
Additionally, women aged 30 and older were more
likely to be taking folic acid than their younger
counterparts at follow-up. At follow-up, nonHispanic Whites reported a 200% improvement in
folic acid compliance. The improvement in folic acid
consumption for non-Hispanic Blacks was also
substantial, although the sample size was too small to
demonstrate significance. At baseline all reported that
they were not currently taking folic acid. At follow
up, all non-Hispanic Blacks reported taking folic
acid. Whereas Site A was successful in changing the
knowledge and behavior of all women who received
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services there, Hispanic women, particularly those of
Mexican origin were particularly well served.
Barriers
Of the women who reported less than daily
multivitamin consumption at Site A, over 65% said
that the size of the pill was a factor in why they didn’t
take the vitamin everyday (Table 3). Less than 11%
of the women with sub-optimal multivitamin
consumption reported that they could not remember
to take the pill. Unknown and other reasons
constituted 20.9% of the reasons that women did not
take the pill daily.
Women of all ages were likely to report the size
of the pill as a barrier to daily multivitamin
consumption, with women aged 25-29 more likely to
report this as an issue than their younger and older
peers. Remembering to take the pill was also a
significant
barrier
for
daily
multivitamin
consumption for older and younger women (12.5%
and 17.6%, respectively), but not for women aged 2529, only 4.4% of whom reported this as a barrier. For
the non-Hispanic Black and White women who
received services from Site A, all (n=8) reported the
size of the pill as a barrier to daily MVC. Among the
Hispanic women served, over 60% reported this as a
barrier.
Best Practices
The Site A model for multivitamin education and
distribution was successful at reaching its mostly
Mexican-Hispanic participants in large part due to the
settings in which Site A clients received services as
well as the provision of culturally relevant
educational materials. Women who received services
at Site A participated in group educational meetings
conducted by Spanish-speaking program providers.
Additionally, clients interacted with the VitaGrant
program on a near daily basis as they sought
childcare at the facility that housed Site A services.
The provision of culturally specific educational
materials contributed greatly to the success of the
VitaGrant program at this site.
We suggest that in order to improve daily folic
acid consumption among Hispanic women, other
intervention programs should pay particular attention
to the size of the multivitamins distributed.
Distributing free multivitamins and culturally
relevant health education materials in the context of a
group setting seems to be an effective way to
improve the daily folic acid consumption of Hispanic
women. Daily interaction with the VitaGrant
participants may also improve the folic acid
consumption patterns of program participants.

Florida Public Health Review, 2009; 6:36-45.
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Site B
Background
Although Black women are not considered at
high risk for NTDs (Bishop & Keller, 2008) as
Mexican-Hispanic women, they have an increased
high risk for poor infant health outcomes. Black
women have higher rates of preterm and low birth
weight births and infant mortality. As such, the
VitaGrant sought to reach Black women with
preconception education as well as multivitamins in
an effort to prevent other poor birth outcomes.
Target Population
The
population
consisted
of
young,
interconceptional non-Hispanic Black women
residing in west central, Florida. These women are
referred for services to Site B based upon the results
of a screening tool administered thorough obstetrical
and hospital providers.
Program Description
Site B is a case management agency that focuses
on preventing low birth weight, infant mortality and
child maltreatment. Site B serves a large proportion
of non-Hispanic Black women less than 25 years of
age. In general, women who received VitaGrant
Program services from this Site were offered services
as a part of an array of services provided, primarily
through paraprofessionals providing home visits at
varying intervals. .
Results of the Program Evaluation
Participation
The 161 women who received VitaGrant services
through Site B were overwhelmingly young and nonHispanic Black (Table 4). A substantial proportion of
women who received VitaGrant Program services at
Site B were younger than 25 years old (47.2%).
Women aged 25-29 made up only about 24% and
women older than 30 made up just over 26% of those
of who received services. Non-Hispanic Black
women made up 60.25% of Site B participants, where
non-Hispanic Whites and Hispanics made up 26.1%
and 8.7%, respectively.
Outcomes
Knowledge. Table 5 shows that participants who
received VitaGrant Program services at Site B
increased their knowledge that folic acid prevents
birth defects dramatically from baseline to follow-up.
At baseline, all Site B participants were similarly
uninformed about folic acid, such that about 81% did
not know that folic acid could prevent birth defects.
Women younger than 25 years old and older than 30
were least likely to report awareness that folic acid
prevented birth defects (18.4% and 19.0%
respectively) than women aged 25-29 who were
slightly more likely to be aware of the preventative
effects of folic acid for birth defects (20.5%).
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Knowledge that folic acid prevents NTDs
increased over 183% from baseline to follow-up for
all groups of women who received services at Site B.
This increase was most substantial for the youngest
women (those 24 years old and younger). At program
onset, only about 18% of these women reported that
they were aware of the preventative effects of folic
acid. This increased over 236% at follow-up where
over 79% of these women reported knowledge that
folic acid prevents birth defects. Women aged 25-29
and over 30 experienced improvements in knowledge
by 236.5% and 251%, respectively.
Whereas non-Hispanic Whites reported the
highest levels of knowledge at follow-up (81.0%
reporting that they were aware that folic acid prevents
birth defects), non-Hispanic Blacks showed the
greatest overall improvement in knowledge. The
increase in knowledge from baseline to follow-up
was over 408% for non-Hispanic Blacks, 299.3% for
Hispanics and was only 183.2% for non-Hispanic
Whites. Whereas the improvement in knowledge for
Hispanic women was substantial, they had the lowest
level of knowledge at the beginning and end of the
program, which underscores the difficulty reaching
this high-risk population and the importance of
delivering health education in a manner that is
culturally specific.
Daily consumption of multivitamins (MVC). At
program onset, only 26% of women receiving
services at Site B were consuming multivitamins 5-7
days a week, which increased to almost 73% at
follow-up (an increase of about 176%). At baseline,
the oldest women in the study were most likely to
respond that they were taking folic acid 5-7 days a
week (47.6%). At follow-up, 66.7% of these women
reported routine vitamin consumption (an
improvement of only about 40%). Women aged 2529 were more likely to be consuming multivitamins
at baseline and follow-up (25.6% and 76.2%
respectively) than women younger than age 25, but
their overall level of improvement was less than that
of younger women. Women younger than 25 had the
lowest levels of baseline daily MVC (15.8%) but
experienced the greatest improvements in
multivitamin consumption compliance at follow up,
an improvement of over 376% to 75.3% reporting
that they consumed multivitamins on a daily basis.
Non-Hispanic White women were more than
twice as likely (47.6%) to be consuming folic acid 57 days a week as non-Hispanic Black (20.6%) and
Hispanic women (14.3%) at baseline. At follow up,
76.2% of non-Hispanic Whites, compared to 73.2%
of non-Hispanic Blacks and 71.4% of Hispanics
reported MVC compliance. Whereas non-Hispanic
Whites reported the highest levels of consumption at
baseline and follow-up, this increase is only about
Florida Public Health Review, 2009; 6:36-45.
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60%. This is substantially less than the increase for
non-Hispanic Black women (255%) and for Hispanic
women (391%), who had the greatest improvement in
daily MVC.
Barriers
The women who reported consuming
multivitamins less than 5-7 days a week were most
likely to cite failing to remember to do so as a barrier
to MVC (57.1%). These women were mostly young
and were both non-Hispanic Black and White. The
next most often cited reason for non-compliance was
the multivitamin pill being too big, which was an
issue for 16.5% of the women who reported less than
optimal multivitamin consumption. This issue was
cited only among women less than 30 years old.
Among the non-Hispanic White women who reported
noncompliance, 16.7% cited this as a reason. Only
12.7% of non-Hispanic Black women cited this
reason for consuming multivitamins less than 5-7
days a week. Hispanic women were twice as likely to
report the pill being too big as a reason for noncompliance, as any other reason.
Best Practices
Site B was somewhat successful at achieving
behavior change among young non-Hispanic Black
women. Overall, knowledge and consumption
improved markedly for Site B participants. Timing
devices might be an important consideration for
improving the multivitamin consumption among nonHispanic Black women, of which 65.5% reported that
remembering to take the multivitamin was a barrier to
daily compliance. We also recommend that the size
of the vitamin pill be an important consideration for
future multivitamin distribution programs, since
clients at both sites cited it as an issue in taking
multivitamins on a daily basis.
Discussion
Both service delivery models offered potential
for marked improvements in the folic acid knowledge
and multivitamin consumption patterns of its
participants.
However, the improvements in
multivitamin knowledge and consumption were
substantially higher for the group setting format
provided through Site A. At follow up, 91.8% of the
women who received services from Site A reported
that they were aware that folic acid prevents birth
defects, and 87.6% reported taking folic acid 5-7 days
a week. Site B clients reported less marked
improvements at follow up, where 73.9% reported
that they were aware of the preventative effects of
folic acid, and 72.7% were taking folic acid daily.
Notably, women who received services from Site A
(who were mostly Mexican-Hispanic) reported low
levels of knowledge and consumption at baseline.
Women who received services from Site B were
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slightly more likely to report knowledge and daily
folic acid consumption (18.6% and 26.1%
respectively) at baseline.
The more diffused model of care that Site B
clients received may be somewhat less effective at
changing folic acid knowledge and consumption
behaviors. Although there are strengths to the Site B
program, the group setting model may be more
effective at changing the folic acid knowledge and
consumption patterns of women aged 14-45.
Because the goal is to get women consuming
multivitamins containing folic acid on a daily basis, it
seems that program models that rely on the daily
interaction of participants with the program may be
most well suited to meet the needs of women who
participate in such programs. Whereas Site A’s
delivery of health care education in conjunction with
childcare resulted in client contact on a daily basis,
there are other ways to get women in such programs
to interact daily with the program. These might
include daily text message reminders, emails and
other forms of communication that remind women to
take their multivitamins. There may also be
opportunities for health education messaging to be
incorporated into other settings where health
education has not traditionally been incorporated, like
grocery stores, places of employment or other places
frequented routinely by the population being sought
to influence.
The limitations to this study are those that are
inherent to many program evaluations. Without a
control group for comparison to these sites, the timeseries data can only say what the total impact of the
media campaign, education, and the free
multivitamins provision had on participants’
knowledge and behavior at follow-up. Consequently,
it is impossible to isolate the impact of any of those
interventions alone. Selection and reporting bias may
have affected the findings. The program participants
may have reported behaviors that the program
promotes and these findings may overestimate
knowledge and consumption of folic acid. Because
data were available only for those women that
remained in the program at follow-up, it is unknown
if women who stayed in the program were more or
less compliant than the women who dropped out.
Despite these shortcomings, the high rates of
overall improvement in regard to folic acid
knowledge and consumption are comparable to other
findings in similar projects in Utah and Western
North Carolina (Nance, 2007, Major 2007). This
suggests that programs that distribute both free
multivitamins
and
preconception
education
(including information about folic acid) seem to
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change the knowledge and multivitamin consumption
behaviors of the women who participate. Women
who were not contemplating birth seem to have
accepted the message that taking multivitamins
improves their overall health and reduces their risk
for having a neural tube defect affected unplanned
pregnancy. It might also suggest that the desire of
some women to decrease their risk of NTD affected
births is worth the expense of providing free
education and multivitamins in health care and social
service delivery. Simply put, women will consume
multivitamins if they have access to free
multivitamins.
There are several strengths to the VitaGrant
program. One is that the service delivery occurred in
the context of overall health. Multivitamins and
preconception educational materials were distributed
in health care and social service settings and in many
instances as part of a “whole health” framework. It
seems that young women and women of Mexican
origin, in particular, were served well by the project.
In large part this is likely due to the efforts made by
program administrators who distributed educational
materials that were culturally appropriate to Hispanic
women. This may have allowed Site A to better able
to educate and change the behavior of Hispanic
Women than Site B. The greater improvements for
Hispanic women at Site A than at Site B may also be
due to the homogeneity of Site A participants and
staff as well as the daily interaction that occurred as
the child care provider to women receiving VitaGrant
services. Although Site B, whose model of service
delivery was more diffused and included some home
visiting with individual participants, was less
successful than Site A in influencing behavior
change, the model of distribution offered through the
site still provides an effective strategy for risk
reduction of neural tube defects.
Preconception intervention programs may wish
to seek out providers that offer the best chance for
reaching and influencing the population in
consideration. Providers that serve a diverse
population through a diffuse array of services may
not be as effective as those providers offering more
intensive services at a higher frequency. Health
education that occurs in the context of group setting
is an effective strategy for changing the knowledge
and behavior patterns of women at risk for poor
health outcomes. Those interested in adopting such a
program would be well-advised to offer a chewable
vitamin alternative. Also, women would benefit from
timing devices, which would help women remember
to take their multivitamins daily.
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Table 2. Consumption and Knowledge for Site A Participants
Site A

Baseline

Overall
Total

Less than 25
years old

25-29 years
old

Older than 30
years old

Non-Hispanic
White

Non-Hispanic
Black

Hispanic

96.6%**
281
3.4%**
10
100.00%
291

95.00%
76
5.00%
4
100.00%
80

96.30%
103
3.70%
4
100.00%
107

100.00%
94
0.00%
0
100.00%
94

100.00%
10
0.00%
0
100.00%
10

100.00%
8
0.00%
0
100.00%
8

97.00%
259
3.00%
8
100.00%
267

93.8%**
273
6.2%**
18
100.00%
291

95.00%
76
5.00%
4
100.00%
80

94.40%
101
5.60%
6
100.00%
107

95.70%
90
4.30%
4
100.00%
94

60.00%
6
40.00%
4
100.00%
10

100.00%
8
0.00%
0
100.00%
8

94.80%
253
5.20%
14
100.00%
267

Overall
Total

Less than 25
years old

25-29 years
old

Older than 30
years old

Non-Hispanic
White

Non-Hispanic
Black

Hispanic

8.2%**
24
91.8%**
267
100.00%
291

10.30%
8
89.70%
70
100.00%
78

11.20%
12
88.80%
95
100.00%
107

4.20%
4
95.80%
92
100.00%
96

20.00%
2
80.00%
8
100.00%
10

0.00%
100.00%
8
100.00%
8

8.20%
22
91.80%
245
100.00%
267

12.4%**
36
87.6%**
255
100.00%
291

15.40%
12
84.60%
66
100.00%
78

16.80%
18
83.20%
89
100.00%
107

4.20%
4
95.80%
92
100.00%
96

0.00%
0
100.00%
10
100.00%
10

0.00%
0
100.00%
8
100.00%
8

13.50%
36
86.50%
231
100.00%
267

Non-Hispanic
White

Non-Hispanic
Black

Hispanic
11.90%

Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects
n
Knows that mv/folic acid prevents birth defects
n
Total
n

Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk.
n
Currently consumes multivitamins/ folic acid 5-7 days/wk.
n
Total
n

Follow-up
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects
n
Knows that mv/folic acid prevents birth defects
n
Total
n

Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk.
n
Currently consumes multivitamins/ folic acid 5-7 days/wk.
n
Total
n

**p<0.01, *p<0.05 for the same indicator comparing baseline to follow-up. About 99 % of Hispanics women are of Mexican origin. Age (n=281), missing=10; Race/Ethnicity (n=285), missing=6

Table 3. Barriers to Compliance to Site A Participants
Site A
Can't remember
n
Pill too big
n
Makes me sick
n
Doesn't seem important
n
Other and Unknown Reasons
n
Total
n

Overall Total

Less than 25
years old

25-29 years Older than 30
old
years old

10.40%

17.60%

4.40%

12.50%

0.00%

0.00%

12

6

2

4

0

0

12

65.20%

58.80%

73.30%

62.50%

100.00%

100.00%

60.40%

75

20

33

20

4

8

61

1.70%

5.90%

0.00%

0.00%

0.00%

0.00%

2.00%

2

2

0

0

0

0

2

1.70%

0.00%

4.40%

0.00%

0.00%

0.00%

2.00%

2

0

2

0

0

0

2

20.90%

17.60%

17.80%

25.00%

0.00%

0.00%

23.80%

24

6

8

8

0

0

24

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

115

34

45

32

4

8

101

Age (n=89), missing=2; Race/Ethnicity (n=87), missing 4
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Table 4. Demographic Characteristics of Site B Participants

Site B
Age
Less than 25 years old
25-29
Older than 30 years old
Missing
Total
Race and Ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Unknown/missing
Total

n
76
39
42
4
161
n
42
97
14
8
161

%
47.20%
24.22%
26.09%
2.48%
100.00%
%
26.09%
60.25%
8.70%
4.97%
100.00%

Table 5. Consumption and Knowledge for Site B participants
Site B

Baseline

Overall
Total

Less than 25
years old

25-29 years
old

Older than 30
years old

Non-Hispanic
White

Non-Hispanic
Black

Hispanic

81.4%**
131
18.6%**
30
100.00%
161

81.60%
62
18.40%
14
100.00%
76

79.50%
31
20.50%
8
100.00%
39

81.00%
34
19.00%
8
100.00%
42

71.40%
30
28.60%
12
100.00%
42

85.60%
83
14.40%
14
100.00%
97

85.70%
12
14.30%
2
100.00%
14

73.9%**
119
26.1%**
42
100.00%
161

84.20%
64
15.80%
12
100.00%
76

74.40%
29
25.60%
10
100.00%
39

52.40%
22
47.60%
20
100.00%
42

52.40%
22
47.60%
20
100.00%
42

79.40%
77
20.60%
20
100.00%
97

85.70%
12
14.30%
2
100.00%
14

Overall
Total

Less than 25
years old

25-29 years
old

Older than 30
years old

Non-Hispanic
White

Non-Hispanic
Black

Hispanic

26.1%**
42
73.9%**
119
100.00%
161

20.50%
15
79.50%
58
100.00%
73

31.00%
13
69.00%
29
100.00%
42

33.30%
14
66.70%
28
100.00%
42

19.00%
8
81.00%
34
100.00%
42

26.80%
26
73.20%
71
100.00%
97

42.90%
6
57.10%
8
100.00%
14

27.3%**
44
72.7%**
117
100.00%
161

24.70%
18
75.30%
55
100.00%
73

23.80%
10
76.20%
32
100.00%
42

33.30%
14
66.70%
28
100.00%
42

23.80%
10
76.20%
32
100.00%
42

26.80%
26
73.20%
71
100.00%
97

28.60%
4
71.40%
10
100.00%
14

Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects
n
Knows that mv/folic acid prevents birth defects
n
Total
n

Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk.
n
Currently consumes multivitamins/ folic acid 5-7 days/wk.
n
Total
n

Follow-up
Knowledge that folic acid prevents birth defects
Does not know if mv/folic acid prevents birth defects
n
Knows that mv/folic acid prevents birth defects
n
Total
n

Current daily consumption
Does not consume multivitamins/folic acid 5-7 days/wk.
n
Currently consumes multivitamins/ folic acid 5-7 days/wk.
n
Total
n

**p<0.01, *p<0.05 for the same indicator comparing baseline to follow-up. Age (n=157), missing=4; Race/Ethnicity (n=153), n=8
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Table 6. Barriers to Compliance for Site B Participants

Site B
Can't remember
n
Pill too big
n
Makes me sick
n
Doesn't seem important
n
Other and Unknown Reasons
n
Total
n

Overall Total

Less than 25
years old

25-29 years
old

57.10%

71.80%

41.70%

46.20%

50.00%

65.50%

52

28

10

12

12

36

2

16.50%

17.90%

33.30%

0.00%

16.70%

12.70%

50.00%

Hispanic
25.00%

15

7

8

0

4

7

4

2.20%

0.00%

0.00%

7.70%

0.00%

3.60%

0.00%

2

0

0

2

0

2

0

8.80%

0.00%

8.30%

23.10%

8.30%

10.90%

0.00%

8

0

2

6

2

6

0

15.40%

10.30%

16.70%

23.10%

25.00%

7.30%

25.00%

14

4

4

6

6

4

2

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

100.00%

91

39

24

26

24

55

8
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